Amarin Corp Plc (AMRN)

[speedrunner]

STS,

Thanks for your input and I hope you are right- that would be even better for AMRN. I was basing my 60 mil estimate based on the Q1-2013 expense noted on their financial statement which stated the cost for study at 15 mil.

This means if they can keep the cost of salaries for 275 sales force and the rest of the employees to a reasonable level. My estimate based on pure speculation is 400 employees at average cost of 160,000 (including benefit) would be 64 mill. I would welcome a more accurate number from someone more knowledgeable.

Cost of the drug at 80 % margin would be around 20 mill dollar per 100 mill in sales. Again, I would appreciate input from others.

What this means is that the break-even point could be around 120 million dollars.

120 million in revenue can be achieved by weekly sales of 12,500 scripts. 12,500 (scripts per week) X 184 (whole sale cost per month)X 52 (total weeks per year) = 120 million.

Currently we are at about 8,000 scripts per week (6500 as reported by Symphony + 20 % under-reporting). If scripts continue at current pace, the weekly scripts will reach 12,500 level some time in Q2 2014.

Bottom-line is we could be in the black sometime mid-2014.